U.S. Software Stock News

NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

Pennant Group (PNTG): Earnings, Revenue Forecasts Outpace Market as Margins Remain Stable

Pennant Group (PNTG) has continued its strong track record, with earnings forecast to grow by 30.38% per year and revenue expected to rise 16.6% annually, both comfortably ahead of US market averages. Over the past five years, the company delivered annual earnings growth of 29.1%, while profit margins held steady at 3.2%. Investors will note the stock trades at a 30.8x Price-To-Earnings ratio, which is higher than most healthcare peers but below the average of its direct competitors. The...
NYSE:BORR
NYSE:BORREnergy Services

Borr Drilling (NYSE:BORR) Margin Miss Reinforces Market Skepticism Despite Steep Valuation Discount

Borr Drilling (NYSE:BORR) posted standout earnings growth over the last five years, averaging a 56% rise annually and turning profitable with a net profit margin of 7.1% this year, down from 8.7% a year ago. However, the outlook has taken a sharp turn, with analysts projecting earnings to drop by 83.4% per year and revenue to decline 0.4% annually over the next three years. The stock currently trades at $3.21, well below its estimated fair value of $6.44. Its price-to-earnings ratio stands at...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Caris Life Sciences (CAI): Revenue Forecast to Rise 21% Annually Heading Into Earnings Season

Caris Life Sciences (CAI) is currently unprofitable, with no clear trend in net profit margin or earnings reported for the past year or five years. Analysts forecast revenue growth at an impressive 21% per year and earnings growth of 129.25% per year, predicting the company will reach profitability within three years. Shares currently trade at $24.61, notably below the estimated fair value of $48.22. While its Price-To-Sales Ratio of 10.7x is higher than the US biotech industry average, it...
NYSE:ALB
NYSE:ALBChemicals

Albemarle (ALB): Ongoing Losses Challenge Bullish Turnaround Narratives Despite Strong Profitability Forecasts

Albemarle (ALB) remains unprofitable, with reported losses having increased at an average rate of 22.5% per year across the last five years and no improvement shown in net profit margins in its most recent filing. Despite these challenges, the company’s earnings are forecast to rebound sharply at a predicted 66.75% annual growth rate, with profitability expected within three years. Revenue is projected to climb by 8.5% per year, which is slower than the US market average of 10.4%. See our...
NasdaqGS:ARAY
NasdaqGS:ARAYMedical Equipment

Accuray (ARAY) Losses Increase 28.3% Annually, Challenging Turnaround Narrative Despite Profitability Forecast

Accuray (ARAY) has remained unprofitable, with losses deepening at an annual rate of 28.3% over the past five years. While revenue is projected to grow at 4.4% per year, which is slower than the broader US market’s 10.4% average, earnings are expected to rise sharply at 116.63% per year. This sets the company on course to become profitable within three years. With a Price-To-Sales Ratio of 0.3x and the current share price trading below the estimated fair value of $5.17, investors are keeping...
NYSE:EHAB
NYSE:EHABHealthcare

Enhabit (EHAB): Widening Losses Challenge Bullish Profitability Narrative Despite Deep Share Discount

Enhabit (EHAB) has posted increasing losses over the last five years, with annual losses expanding at a rate of 55.2%. Revenue is expected to grow at 5.5% per year, which trails the 10.4% annual growth forecast for the broader US market. Despite these ongoing losses, EHAB is projected to turn profitable within the next three years. Earnings are forecast to grow at 15.3% annually. See our full analysis for Enhabit. Next, let’s see how these latest figures compare to the narratives commonly...
NYSE:TALO
NYSE:TALOOil and Gas

Talos Energy (TALO): Revenue Forecast to Decline 3.4% Annually, Valuation Discount Sharpens Investor Debate

Talos Energy (TALO) remains unprofitable, with forecasts calling for continued losses over the next three years and revenue projected to decline at an annual rate of 3.4%. Over the past five years, the company has narrowed its losses by 28.1% per year, but has not yet shown improved earnings margins due to persistent negative results. While near-term prospects remain pressured, investors may see potential amid ongoing loss reduction and a significant valuation discount compared to peers. See...
NasdaqGS:BMBL
NasdaqGS:BMBLInteractive Media and Services

Bumble (BMBL) Revenue Projected to Decline 5.2% Yearly, Turnaround Hopes Center on Profit Growth

Bumble (BMBL) faces a mixed outlook this earnings season, with revenue forecast to decline by 5.2% per year over the next three years and net losses growing at an annual rate of 61.9% over the past five years. Despite the current losses, earnings are expected to surge by 101.57% annually, with profitability anticipated within the next three years. Investors may view Bumble's below-average Price-to-Sales Ratio and trading price, along with minor risks and a limited risk profile, as potential...
NasdaqCM:ARKO
NasdaqCM:ARKOSpecialty Retail

Arko (ARKO) Reports Flat Margin, Challenging Hopes for Turnaround in Profit Growth

Arko (ARKO) reported a net profit margin of 0.2%, flat compared to last year, as earnings fell by an average of 8.3% per year over the past five years and continued to decline in the most recent period. Revenue is forecast to shrink at a pace of 2.6% per year over the next three years. However, earnings are projected to rebound, with analysts expecting annual growth of 16.5%, which could outpace the broader US market's anticipated 15.8% a year. Despite recent margin pressures and a high...
NasdaqGS:HEPS
NasdaqGS:HEPSMultiline Retail

Hepsiburada (NasdaqGS:HEPS) Trades at 0.5x Sales with 27.7% Projected Annual Revenue Growth Heading into Earnings

D-Market Elektronik Hizmetler ve Ticaret (NasdaqGS:HEPS) remains unprofitable, with losses having widened over the past five years at an average rate of 4.4% annually. Despite the ongoing lack of positive net margin, analysts now project a transition to profitability within three years, while revenue is forecast to accelerate at 27.7% per year, well ahead of the broader US market’s 10.4% pace. Coupled with earnings growth expectations of 143.66% per year and a share price of $2.31 trading at...
NasdaqGS:STKL
NasdaqGS:STKLFood

SunOpta (STKL): One-Off $11.8M Loss Challenges Profit Growth Narrative Despite High Valuation

SunOpta (STKL) has turned profitable, posting average earnings growth of 39% per year over the last five years, though recent figures were affected by a one-off $11.8 million loss that weighed on reported results. Looking ahead, analysts expect the company’s earnings to accelerate at a striking 100.7% annual rate, outpacing the broader US market forecast of 15.8%. Meanwhile, revenue is projected to grow at a slower 7.5% per year compared to the market’s 10.4% average. See our full analysis...
NYSE:OPLN
NYSE:OPLNCommercial Services

OPENLANE (KAR): Profit Margins Surge to 5.8%—Reinforcing Bullish Growth Narratives

OPENLANE (KAR) posted earnings growth of 427.9% over the past year, a striking leap compared to the five-year average of 27.6% per year. Margins have climbed to 5.8% from 1.2% last year, while the company's annual earnings are forecast to outpace the broader US market with 23.9% growth. With a current share price of $24.94 trading below some estimates of fair value and ongoing questions about financial strength, investors are weighing robust profit expansion against persistent balance sheet...
NYSE:ZIP
NYSE:ZIPInteractive Media and Services

ZipRecruiter (ZIP) Losses Deepen 37.9% Annually, Unprofitability Challenges Value Narrative

ZipRecruiter (ZIP) saw its losses deepen at a 37.9% annual rate over the past five years, with the company remaining unprofitable throughout this period. Revenues are projected to grow at 7.4% per year, noticeably slower than the US market average of 10.4% per year. This keeps net profit margins and earnings growth comparisons off the table for now. For investors, the key takeaway is that while shares trade below both industry price-to-sales averages and an indicated fair value of $6.05,...
NYSE:FIG
NYSE:FIGSoftware

Figma (FIGMA) Faces Scrutiny as Revenue Growth Outpaces Market but Losses Persist

Figma (FIGMA) posted annual revenue growth of 18.5%, outpacing the US market average of 10.4%. However, the company remains unprofitable and is expected to stay in the red for at least the next three years. The current share price of $45.98 trades at a premium to estimated fair value. Investors are eyeing Figma’s high growth trajectory, but persistent losses and a lofty price-to-sales ratio are putting its valuation under the microscope. See our full analysis for Figma. Now, let’s see how...
NasdaqCM:OCGN
NasdaqCM:OCGNBiotechs

Ocugen (OCGN): Valuation Pressures Challenge Bullish Narrative as Profitability Remains Elusive

Ocugen (OCGN) is projected to deliver rapid revenue growth of 75.3% per year, with earnings expected to rise 77.45% annually, both far exceeding the broader US market estimates. The company remains unprofitable, having posted a 3.8% average annual increase in losses over the past five years, and its share price currently trades at $1.38. Investors will weigh these aggressive growth forecasts against Ocugen’s continued net margin struggles and premium valuation, especially given a...
NYSE:NXDR
NYSE:NXDRInteractive Media and Services

Nextdoor (NXDR) Losses Worsen, Undermining Profitability Narratives Despite Shares Trading Below Fair Value

Nextdoor Holdings (NXDR) remains unprofitable, with losses increasing at a rate of 2.5% per year over the past five years. While revenue is forecast to grow at 7.8% per year, this trails the broader US market’s expected pace of 10.4% per year. For investors, shares are currently trading at $1.67, below an estimated fair value of $3.48. However, profitability challenges and a higher-than-average Price-To-Sales ratio compared to peers continue to weigh on the outlook. See our full analysis for...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

Root (ROOT) Profitability Surges, Outpacing Market Growth Expectations This Earnings Season

Root (ROOT) turned heads this earnings season as it crossed into profitability over the past year, with revenue forecast to climb 10.9% per year, outpacing the broader US market’s 10.4%. Earnings are expected to accelerate by 22.1% annually, while the company’s past five-year earnings growth of 46.2% per year stands out for its high quality and positive net profit margin trend. With no material risks flagged and a rewards-heavy outlook, investors appear focused on above-market growth...
NYSE:UIS
NYSE:UISIT

Unisys (UIS) Loss Reduction Slows but Profitability Remains Elusive Versus Market Expectations

Unisys (UIS) posted revenue growth forecasts of 4.3% per year, lagging behind the broader US market’s 10.4% annual expectation. The company remains unprofitable, but has managed to narrow its losses at a 9.4% annual rate over the last five years, and shares are currently trading at $2.69, well below the estimated fair value of $20.76. Investors are weighing the progress in shrinking losses and attractive sales multiples against sustained unprofitability and subdued growth projections, with...
NYSE:KMPR
NYSE:KMPRInsurance

Is Kemper Attractively Priced After 35% Drop and Regulatory Shifts in 2025?

Ever wondered if Kemper might be trading at a bargain price, especially after so much market noise around insurance stocks? Kemper's share price has recently dropped by 5.9% over the past week and is down nearly 35% year-to-date, raising eyebrows about both risk and potential upside. Some of these sharp movements align with recent reports highlighting regulatory developments in the insurance sector and industry-wide shakeups impacting underwriting guidelines. Both factors have investors...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

LivaNova (LIVN): Loss Reduction and Profitability Forecast Bolster Bull Case Despite Slower Revenue Growth

LivaNova (LIVN) remains in the red, but the company has made significant progress by narrowing its losses at an annual rate of 42.1% over the past five years. While margins failed to show improvement, investors are paying attention to an expected 32.89% earnings growth per year and the prospect of reaching profitability within three years, which would be well ahead of the broader market's pace. See our full analysis for LivaNova. Now, let’s see how these headline results compare to the...
NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

SolarEdge (SEDG): Losses Have Grown 80% Annually as Profitability Forecasts Face Volatility Narratives

SolarEdge Technologies (SEDG) continues to report losses, with the company’s net losses having increased at an annual rate of 80.2% over the past five years and no signs yet of margin improvement or higher quality earnings. Despite this challenging backdrop, SEDG shares are trading at $41.02, well below its estimated fair value of $62.94. Valuation metrics like a Price-to-Sales Ratio of 2.6x suggest a potential discount relative to sector peers. Looking ahead, earnings are forecast to grow...
NYSE:FNB
NYSE:FNBBanks

Is F.N.B Fairly Priced After Expansion and Strong Five Year Gains?

Ever wondered if F.N.B is trading at a fair price or if there's hidden value to uncover? You are not alone. Understanding what drives the stock's worth can make all the difference for investors looking for the next opportunity. In the last year, F.N.B's stock has dropped 2.2%, but it has delivered a solid 9.1% gain year-to-date and is up a remarkable 123.2% over the past five years. This suggests shifting market sentiment and possible growth potential. Recent headlines highlight F.N.B's...
NYSE:SRE
NYSE:SREIntegrated Utilities

Sempra (SRE): Net Profit Margin Drops to 20%, Testing Bullish Growth and Valuation Narratives

Sempra (SRE) reported current net profit margins of 20%, down from 22.1% the previous year. Its earnings have continued to grow at a 15.2% annualized pace over the last five years. Looking ahead, the company expects approximately 9.1% earnings growth per year and projects a 1.7% annual increase in revenue. With solid profit and revenue forecasts, investors are now weighing the company’s track record and future outlook alongside questions about valuation and risk. See our full analysis for...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

Garrett Motion Shares Soar 132% as EV Partnerships Spark Debate on True Value

Thinking about whether Garrett Motion could be undervalued, a hidden gem, or finally catching up to its true worth? Let’s dig into what might set this stock apart for value-conscious investors. Shares have surged, gaining 29.8% in the last month and skyrocketing 132.4% over the past year, signaling that the market is waking up to something new here. Fueling these moves are headlines about Garrett Motion’s innovative expansion into electric vehicle technologies and strategic partnerships with...